Bristol-Myers Squibb Company Profile Avatar - Palmy Investing

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The compan…

Drug Manufacturers - General
US, New York [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
Holzer Phil M
SVP and Controller
11/05/24 [Form 4]
Shanahan Karin
EVP, Glob. Prod. Dev. & Supply
11/05/24 [Form 4]
Meyers Gregory Scott
EVP, Chief Digital & Tech Off.
11/05/24 [Form 4]
Boerner Christopher S.
Chief Executive Officer
Also inside the BofD
11/05/24 [Form 4]
Hirawat Samit
EVP,Chief Med.Offr.,Drug Dev.
11/05/24 [Form 4]
Gallman Cari
EVP, Corporate Affairs
10/03/24 [Form 4]
Lenkowsky Adam
EVP, Chief Commercial Officer
05/03/24 [Form 4]
Leung Sandra
EVP, General Counsel
03/12/24 [Form 4]
Plenge Robert M
EVP, Chief Research Officer
03/12/24 [Form 4]
Poole Ahn Amanda
EVP, Chief Human Resources
03/12/24 [Form 4]
Hoch Lynelle
President, Cell Therapy Org.
03/12/24 [Form 4]
Hickey Benjamin
President, RayzeBio Org.
03/12/24 [Form 4]
Elkins David V
EVP, Chief Financial Officer
03/12/24 [Form 4]
Caforio Giovanni
Executive Chair of the Board
Also inside the BofD
03/12/24 [Form 4]
End of BMY's Analysis
CIK: 14272 CUSIP: 110122108 ISIN: US1101221083 LEI: - UEI: -
Secondary Listings